Maccura Biotechnology Co.Ltd (300463.SZ)
CNY 13.88
(0.51%)
CNY 13.88
(0.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.89 Billion | 3.6 Billion | 3.98 Billion | 3.7 Billion | 3.22 Billion | 2.68 Billion |
| Cost of Revenue | 1.38 Billion | 1.65 Billion | 1.67 Billion | 1.73 Billion | 1.55 Billion | 1.29 Billion |
| Gross Profit | 1.51 Billion | 1.95 Billion | 2.3 Billion | 1.96 Billion | 1.67 Billion | 1.39 Billion |
| Operating Expenses | 1.18 Billion | 1.06 Billion | 1 Billion | 868.31 Million | 865.97 Million | 713.8 Million |
| Selling, General and Administrative Expenses | 714.55 Million | 674.12 Million | 701.31 Million | 586.41 Million | 608.44 Million | 494.04 Million |
| Research and Development Expenses | 324.16 Million | 273.22 Million | 207.26 Million | 202.07 Million | 140.13 Million | 108.79 Million |
| Other Expenses | 141.69 Million | 114.36 Million | 95.26 Million | 79.82 Million | 117.39 Million | -1.56 Million |
| Cost and Expenses | 2.56 Billion | 2.71 Billion | 2.67 Billion | 2.6 Billion | 2.41 Billion | 2 Billion |
| Operating Income | 331.14 Million | 817.39 Million | 1.21 Billion | 989.69 Million | 695.83 Million | 598.24 Million |
| Interest Expense | 34.45 Million | 35.05 Million | 59.27 Million | 68.18 Million | 67.32 Million | 47.42 Million |
| Income Tax Expense | 689.89 Thousand | 87.68 Million | 184.87 Million | 148.41 Million | 127.48 Million | 113.76 Million |
| Earnings before Tax | 305.36 Million | 789.08 Million | 1.18 Billion | 969.76 Million | 693.17 Million | 596.68 Million |
| Net Income | 312.61 Million | 708.18 Million | 956.6 Million | 793.91 Million | 525.26 Million | 444.92 Million |
| Earnings Per Share Basic | 0.51 | 1.17 | 1.73 | 1.43 | 0.95 | 0.80 |
| Earnings Per Share Diluted | 0.51 | 1.16 | 1.72 | 1.42 | 0.94 | 0.80 |
| Weighted Average Shares Outstanding | 612.49 Million | 603.95 Million | 552.69 Million | 553.98 Million | 553.25 Million | 553.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 612.49 Million | 607.78 Million | 556.81 Million | 557.4 Million | 557.72 Million | 553.46 Million |
| Gross Margin | 0.52 | 0.54 | 0.58 | 0.53 | 0.52 | 0.52 |
| EBIT Margin | 0.23 | 0.32 | 0.38 | 0.35 | 0.30 | 0.30 |
| Profit Margin | 0.11 | 0.20 | 0.24 | 0.21 | 0.16 | 0.17 |
| EBITDA | 651.98 Million | 1.09 Billion | 1.48 Billion | 1.24 Billion | 915.99 Million | 765.89 Million |
| Earnings Before Tax Margin | 0.11 | 0.23 | 0.30 | 0.27 | 0.22 | 0.22 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 668.7 Million | 654.72 Million | 612.33 Million | 780.68 Million | 2.89 Billion | 734.35 Million |
| Cost of Revenue | 283.77 Million | 354.91 Million | 262.49 Million | 342.11 Million | 1.29 Billion | 309.5 Million |
| Gross Profit | 384.92 Million | 299.81 Million | 349.83 Million | 438.57 Million | 1.6 Billion | 424.85 Million |
| Operating Expenses | 266.68 Million | 213.21 Million | 217.88 Million | 391.43 Million | 1.14 Billion | 271.72 Million |
| Selling, General and Administrative Expenses | 423.96 Million | 130.09 Million | 158.27 Million | 168.54 Million | - | 239.78 Million |
| Research and Development Expenses | 78.6 Million | 79.77 Million | 59.52 Million | 106.99 Million | - | 88.59 Million |
| Other Expenses | -235.88 Million | -3.34 Million | -93.67 Thousand | -15.33 Million | -25.77 Million | 2.77 Million |
| Cost and Expenses | 550.46 Million | 568.12 Million | 480.38 Million | 733.55 Million | 2.44 Billion | 581.22 Million |
| Operating Income | 94.5 Million | 86.6 Million | 131.95 Million | 25.09 Million | 331.14 Million | 117.63 Million |
| Interest Expense | 3.46 Million | 5.72 Million | 5.94 Million | 8.89 Million | 33.53 Million | 9.17 Million |
| Income Tax Expense | 7.53 Million | 8.9 Million | 11.73 Million | -26.88 Million | 689.89 Thousand | 16.79 Million |
| Earnings before Tax | 88.14 Million | 87.15 Million | 135.98 Million | 9.76 Million | 305.36 Million | 113.09 Million |
| Net Income | 79.64 Million | 81.28 Million | 120.44 Million | 43.94 Million | 312.61 Million | 93.84 Million |
| Earnings Per Share Basic | 0.13 | 0.13 | 0.20 | 0.07 | - | 0.15 |
| Earnings Per Share Diluted | 0.13 | 0.13 | 0.20 | 0.07 | - | 0.15 |
| Weighted Average Shares Outstanding | 612.46 Million | 612.46 Million | 602.21 Million | 612.46 Million | 608.68 Million | 612.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 612.46 Million | 612.46 Million | 602.21 Million | 612.46 Million | 612.49 Million | 612.46 Million |
| Gross Margin | 0.58 | 0.46 | 0.57 | 0.56 | 0.55 | 0.58 |
| EBIT Margin | 0.14 | 0.24 | 0.24 | 0.04 | - | 0.22 |
| Profit Margin | 0.12 | 0.12 | 0.20 | 0.06 | 0.11 | 0.13 |
| EBITDA | 91.6 Million | 159.31 Million | 149.85 Million | 32.36 Million | - | 158.93 Million |
| Earnings Before Tax Margin | 0.14 | 0.13 | 0.22 | 0.03 | 0.11 | 0.16 |
SPRINT
UGPA3
BLLB
2643
ALL
DLICY